Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Meningococcal disease
2021
2013
Americas
Western Pacific
Clear all
Type of publications
NITAG documentation
(75)
Systematic reviews (SYSVAC)
(7)
Topics
Available to download in languages
Regions
Americas
(68)
Western Pacific
(14)
Africa
(17)
Europe
(78)
South-East Asia
(2)
Countries
Argentina
(1)
Australia
(11)
Bolivia
(2)
Canada
(17)
Chile
(9)
China
(3)
United States of America
(39)
Diseases
COVID-19
(78)
Meningococcal disease
(4)
Ebola
(1)
Haemophilus influenzae type B
(3)
Herpes zoster
(1)
Human papillomavirus (HPV)
(10)
Influenza
(7)
Japanese encephalitis
(1)
Measles
(1)
Pertussis
(2)
Pneumococcal disease
(5)
Rabies
(1)
Rotavirus
(2)
Varicella
(2)
Vaccine topics
Acceptance
(1)
Coverage
(1)
Ethical issues
(2)
Safety
(1)
Target population
Adults
(4)
All age groups
(5)
Children
(3)
Healthcare workers
(1)
Older adults
(3)
Parents/caregivers
(1)
Pregnant women
(5)
Publication date
2021
(79)
2013
(3)
2024
(1)
2023
(17)
2022
(56)
2019
(7)
2018
(5)
2017
(2)
2016
(10)
2015
(5)
2014
(7)
2011
(3)
2010
(1)
2009
(1)
2008
(1)
2007
(2)
2006
(3)
2005
(1)
1997
(1)
82 results found
2021
∙
NACI
Rapid response: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 vaccines
2021
∙
CoNaIn
Recommendation on the administration of additional doses for vaccination against COVID-19
2021
∙
NACI
Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5-11 years of age
2021
∙
NACI, Public Health Agency of Canada
Recommendations on the use of COVID-19 Vaccines
2021
∙
NACI
Recommendations on the use of COVID-19 Vaccines
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine
2021
∙
ACIP
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update of ACIP - 9 July 2021
2013
∙
NACI
Update on the Use of Quadrivalent Conjugate Meningococcal Vaccines
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register